Amanta Healthcare Ltd. IPO Details – Price, Date, GMP & Analysis
Open
Mainboard
Price Range:
Rs.126
Issue Size:
Rs.126.00 Cr
Lot Size:
119 shares
Open Date:
September 1
Amanta Healthcare Ltd. IPO Overview
Bidding Dates
September 1 - September 3
Min Investment
₹14,994
Price Range
₹126
Issue Size
₹126.00 Cr
IPO DRHP Doc
Company Overview
Amanta Healthcare Limited, incorporated in December 1994, is a pharmaceutical company focused on developing, manufacturing, and marketing sterile liquid products, particularly parenteral products. They utilize Aseptic Blow-Fill-Seal and Injection Stretch Blow Moulding technologies. The company produces fluid therapy formulations, medical devices, and over 45 generic products, distributing them through 320 distributors in India and exporting to 21 countries. Their products are registered in 19 countries and meet various regulatory standards.
IPO Timeline
Opens
Sep 1
Closes
Sep 3
Allotment
Sep 4
Refunds
Sep 8
Shares Credit
Sep 8
Listing
Sep 9
Opens
Sep 1
Closes
Sep 3
Allotment
Sep 4
Refunds
Sep 8
Shares Credit
Sep 8
Listing
Sep 9
Latest Subscription Data
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 0.53x | Partially Subscribed |
| NII (Non-Institutional Investors/HNI) | 36.41x | Oversubscribed |
| RII (Retail Individual Investors) | 23.35x | Oversubscribed |
| Total Subscription | 19.63x | Oversubscribed |
Last updated: Sep 2, 2025, 05:06 PM
Current GMP:
Rs.12
Est. Listing:
Rs.138
Est. Gain:
+9.5%
Star Rating:
★★★★★(2/5)
Financial Information
Financial Data Table
Detailed breakdown of financial metrics across years
| Financial Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | ₹381.76 Cr | ₹352.12 Cr | ₹374.06 Cr |
| EBITDA | ₹61.05 Cr | ₹58.76 Cr | ₹56.31 Cr |
| Net Worth | ₹96.39 Cr | ₹66.29 Cr | ₹62.88 Cr |
| Profit After Tax | ₹10.5 Cr | ₹3.63 Cr | ₹2.11 Cr |
| Reserves and Surplus | ₹67.56 Cr | ₹39.46 Cr | ₹36.05 Cr |
| Total Borrowing | ₹195 Cr | ₹205.23 Cr | ₹215.66 Cr |
| Total Income | ₹276.09 Cr | ₹281.61 Cr | ₹262.7 Cr |
Financial data is visualized in the chart above
Strengths & Risks Analysis
Key Strengths
Competitive advantages and positive aspects
- Established in 1994 with diversified pharmaceutical product portfolio
- Advanced sterile liquid manufacturing across wide volume range
- Certified facility with ISO, WHO-GMP, and advanced technologies
- Extensive domestic and global distribution and sales network
- Experienced leadership with skilled, qualified employee base
IPO Details
Amanta Healthcare IPO Details
| [.] | |
| ₹10 per share | |
| ₹126 per share | |
| 1,00,00,000 shares (aggregating up to ₹126.00 Cr) | |
| 119 Shares | |
| 2,88,29,351 shares | |
| 3,88,29,351 shares | |
| BSE, NSE | |
| IPO Date | September 1, 2025 to September 3, 2025 |
| Issue Type | Bookbuilding IPO |
| Sale Type | Fresh Capital |
Amanta Healthcare IPO Reservation
Share Reservation Distribution
QIB
5,000,000 shares (50%)
Retail
3,500,000 shares (35%)
Anchor Investors
3,000,000 shares (30%)
QIB (Ex-Anchor)
2,000,000 shares (20%)
HNI (NII)
1,500,000 shares (15%)
bNII (>₹10L)
1,000,000 shares (10%)
sNII (<₹10L)
500,000 shares (5%)
Amanta Healthcare IPO Promoter Holding
| Promoter Holding Post Issue | 63.56% |
| Promoter Holding Pre Issue | 85.60% |
Key Dates
Open Date:September 1
Close Date:September 3
Listing Date:TBA
